Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae

Vaccine

Volumn 32, Issue 5, 2014, Pages 544-551

  Pakkanen, Sari H ^a,b   Kantele, Jussi M ^c   Herzog, Christian ^d   Kantele, Anu ^a,b,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antibody secreting cell; Cross reactive; Non typhoid Salmonella; Salmonella Typhi Ty21a; Typherix; Vi polysaccharide

Indexed keywords

HOMING RECEPTOR; L SELECTIN; O 12 ANTIGEN; O 9 ANTIGEN; O ANTIGEN; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MIDDLE AGED; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA; SALMONELLA AGONA; SALMONELLA ENTERITIDIS; SALMONELLA HADAR; SALMONELLA STANLEY; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SALMONELLA VIRCHOW; SEROTYPE; VACCINATION; YOUNG ADULT;

ALS; ANTIBODIES IN LYMPHOCYTE SUPERNATANTS; ANTIBODY-SECRETING CELL; ASC; CLA; CROSS-REACTIVE; CUTANEOUS LYMPHOCYTE ANTIGEN; HOMING RECEPTOR; HR; INTS; INVASIVE NON-TYPHOID SALMONELLA; NON-TYPHOID SALMONELLA; NTS; PBMC; PBS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHOSPHATE BUFFERED SALINE; SALMONELLA TYPHI TY21A; TYPHERIX; VI POLYSACCHARIDE;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; CROSS REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; O ANTIGENS; POLYSACCHARIDES, BACTERIAL; SALMONELLA; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; YOUNG ADULT;

EID: 84891664919     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.001     Document Type: Article

References (37)

1. Kantele A., Pakkanen S.H., Siitonen A., Karttunen R., Kantele J.M. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid Salmonellae?. Vaccine 2012, 50:7238-7245.
2. Kantele A., Pakkanen S.H., Karttunen R., Kantele J.M. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines - a randomized clinical trial. PLoS ONE 2013, 8(4):e60583.
3. Centers for Disease Control and Prevention (CDC) National Salmonella surveillance annual data summary 2009, US Department of Health and Human Services, CDC 2011, Atlanta, GA, (accessed 19.05.13). http://www.cdc.gov/ncezid/dfwed/PDFs/salmonella-annual-summary-2009-508c.pdf.
4. Majowicz S.E., Musto J., Scallan E., Angulo F.J., Kirk M., O'Brien S.J., et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 2010, 50:882-889.
5. Gordon M.A., Banda H.T., Gondwe M., Gordon S.B., Boeree M.J., Walsh A.L., et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002, 16:1633-1641.
6. Berkley J.A., Lowe B.S., Mwangi I., Williams T., Bauni E., Mwarumba S., et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005, 352:39-47.
7. Brent A.J., Oundo J.O., Mwangi I., Ochola L., Lowe B., Berkley J.A. Salmonella bacteremia in Kenyan children. Pediatr Infect Dis J 2006, 25:230-236.
8. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., et al. Epidemics of invasive Salmonella enterica serovar Enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 2008, 46:963-969.
9. MacLennan C.A., Gondwe E.N., Msefula C.L., Kingsley R.A., Thomson N.R., White S.A., et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 2008, 118:1553-1562.
10. Feasey N., Dougan G., Kingsley R.A., Heyderman R.S., Gordon M.A. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
11. The community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2006. EFSA J 2007, 130:2-352. Available from http://www.efsa.europa.eu/en/scdocs/scdoc/130r.htm (accessed 19.05.13).
12. Grimont P.A.D., Weill F.-X. Antigenic formulae of the Salmonella serovars 2007, WHO, Available from http://nih.dmsc.moph.go.th/aboutus/media/antigenic%20formula%20of%20Salmonella.pdf (accessed 19.05.13).
13. Su L.H., Chiu C.H., Chu C., Ou J.T. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004, 39:546-551.
14. Koluman A., Dikici A. Antimicrobial resistance of emerging foodborne pathogens: status quo and global trends. Crit Rev Microbiol 2013, 39:57-69.
15. Kantele A., Arvilommi H., Jokinen I. Specific immunoglobulin-secreting human blood cells after peroral immunization against Salmonella typhi. J Infect Dis 1986, 153:1126-1131.
16. Kantele A. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 1990, 8:321-326.
17. Kantele A., Kantele J.M., Savilahti E., Westerholm M., Arvilommi H., Lazarovits A., et al. Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997, 158:574-579.
18. Kantele A., Westerholm M., Kantele J.M., Mäkelä P.H., Savilahti E. Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine 1999, 17:229-236.
19. Kantele J.M., Arvilommi H., Kontiainen S., Salmi M., Jalkanen S., Savilahti E., et al. Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology 1996, 110:1061-1067.
20. Kantele A. Persistence of diarrheal pathogens is associated with continued recruitment of plasmablasts in the circulation. Clin Dev Immunol 2012, 279206.
21. Kantele A., Mäkelä P.H. Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine 1991, 9:423-427.
22. Berlin C., Berg E.L., Briskin M.J., Andrew D.P., Kilshaw P.J., Holzmann B., et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993, 74:185-195.
23. Camerini D., James S.P., Stamenkovic I., Seed B. Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor. Nature 1989, 342:78-82.
24. Picker L.J., Kishimoto T.K., Smith C.W., Warnock R.A., Butcher E.C. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991, 349:796-799.
25. Kantele A., Arvilommi H., Kantele J.M., Rintala L., Mäkelä P.H. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microb Pathog 1991, 10:117-126.
26. Pakkanen S.H., Kantele J.M., Kantele A. Cross-reactive gut-directed immune response against Salmonella Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination. Vaccine 2012, 30:6047-6053.
27. Kantele A., Papunen R., Virtanen E., Möttönen T., Räsänen L., Ala-Kaila K., et al. Antibody-secreting cells in acute urinary tract infection as indicators of local immune response. J Infect Dis 1994, 169:1023-1028.
28. Lue C., Tarkowski A., Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol 1988, 140:3793-3800.
29. Tacket C.O., Ferreccio C., Robbins J.B., Tsai C-M., Schulz D., Cadoz M., et al. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis 1986, 154:342-345.
30. Jolliff C.R., Cost K.M., Stivrins P.C., Grossman P.P., Nolte C.R., Franco S.M., et al. Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem 1982, 28:126-128.
31. MacLennan C.A., Gilchrist J.J., Gordon M.A., Cunningham A.F., Cobbold M., Goodall M., et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 2010, 328:508-512.
32. Michetti P., Mahan M.J., Slauch J.M., Mekalanos J.J., Neutra M.R. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992, 60:1786-1792.
33. Michetti P., Porta N., Mahan M.J., Slauch J.M., Mekalanos J.J., Blum A.L., et al. Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology 1994, 107:915-923.
34. Iankov I.D., Petrov D.P., Mladenov I.V., Haralambieva I.H., Kalev O.K., Balabanova M.S., et al. Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis. Microb Infect 2004, 6:901-910.
35. Mantis N.J., Forbes S.J. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest 2010, 39:383-406.
36. Endt K., Stecher B., Chaffron S., Slack E., Tchitchek N., Van Maele L., et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 2010, 6:e1001097.
37. Laupland K., Schønheyder H., Kennedy K., Lyytikäinen O., Valiquette L., Galbraith J., et al. Salmonella enterica bacteraemia: a multi-national population-based cohort study. BMC Infect Dis 2010, 10:95.